Zoetis (ZTS) closed at $74.07 in the latest trading session, marking a -1.75% move from the prior day.
Zoetis has long been viewed as a high-quality compounder. However, after reaching an all-time high of $249.27 in December 2021, the stock is now caught in a ~70% drawdown. This can be primarily attributed to the dismal performance of the company's crown jewel asset, namely the U.S. companion animal business. After delivering an impressive 25% organic growth during the full year of 2021, the U.S. companion animal business reported dismal performance in Q1-26, with an organic decline of 11%.
Zoetis wins EU approval for a single-dose poultry vaccine against Newcastle and Marek's diseases, expanding its vaccine portfolio and flock protection options.
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| TJD Thomas John Drogan PR Inc.IPAL SECURITIES Inc. | 16,902 | $2.67M | $1.27M | -$1.4M | -52.62% |
| DI David Izzi Brown, LISLE/CUMMINGS Inc. | 1,525 | $313,143.18 | $114,138.62 | -$199,004.56 | -63.55% |
| TMB Timothy M. Bidwell Hazlett, BURT & WATSON Inc. | 318 | $50,336.11 | $23,800.71 | -$26,535.4 | -52.72% |
| LC Lisa Candera CIGNA INVESTMENTS Inc. /NEW | 4,175 | $577,581.97 | $312,477.87 | -$265,104.1 | -45.9% |
| CE Curtis Ellergodt Rothschild Investment LLC | 2,142 | $403,873.87 | $160,317.99 | -$243,555.88 | -60.3% |
| Specialty Retail Industry | Consumer Discretionary Sector | Kristin C. Peck CEO | NYSE Exchange | 98978V103 CUSIP |
| US Country | 13,800 Employees | 20 Jul 2026 Last Dividend | - Last Split | 1 Feb 2013 IPO Date |
Zoetis Inc. is a global leader in the discovery, development, manufacture, and commercialization of a wide range of animal health medicines, vaccines, and diagnostic products. Founded in 1952 and based in Parsippany, New Jersey, the company addresses the health needs of both livestock—including cattle, swine, poultry, fish, and sheep—and companion animals, such as dogs, cats, and horses. With a presence in both the United States and international markets, Zoetis delivers products and services designed to meet the complex challenges of animal health, ensuring the well-being of animals across the globe. The company's extensive product line-up, alongside innovative diagnostic solutions, makes it a vital player in promoting animal health and supporting the veterinarians, livestock producers, and pet owners who care for them.
Zoetis Inc. offers an expansive portfolio of products and services designed to enhance animal health and support the professionals who work with animals. These include: